维普期刊资源整合服务平台（V6.5）

335篇 您的检索式：作者名="Viberti"

选中清除导出查看参考文献查看引证文献引用追踪共17页首页上一页第1页下一页末页 /17 跳转

	题名	作者	年代	出处	被引量
1	Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus: A Blood Pressure–Independent Effect显示文摘	Giancarlo Viberti Nigel M. Wheeldon	2002	Circulation: Journal of the American Heart Association2002，，6：	2
2	Pathogenesis of diabetic nephropathy显示文摘	Raptis AE Viberti G	2001	Exp Clin Endocr Diab2001，109，2：	1
3	Rosiglitazone reduces urinary albumin excretion in type 2 diabetes显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
4	Management to optimize organ procurement in brain dead donors 显示文摘	Mascia L Mastromauro I Viberti S	2009	Minerva Anestesiol2009，75，3：	1
5	Microalbuminuria re- duction with valsartan in patients with type 2 diabetes mellitus:a blood pressure independent effect显示文摘	VIBERTI G WHEELDON NM Microalbuminuria Reduction with Valsartan (MARVAL) Study Investigators	2002	Circulation2002，106，6：	1
6	Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellims: a blood pressure-independent effect 显示文摘	Viberti G Whecldon NM MicroAlbuminuria Reduction With VALsartan (MARVAL) Study investigators	2002	Circulation2002，106，6：	1
7	Rosiglitazone reduces urinary albumin excretion in type Ⅱ diabetes显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
8	Preventing mieroalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Mieroalbuminufia Prevention (ROAD MAP) study显示文摘	Hailer H Viberti GC Mimran A	2006	J Hypertens2006，24，2：	1
9	Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus显示文摘	Hollenberg NK Parving HH Viberti G	2007	J Hypertens2007，25，9：	1
10	Beta 2 - microglobulin : a sensitive index of diminishing renal function in diabetics 显示文摘	Viberti GC	2002	Br Med J2002，282，：	1
11	Micro-albuminuria and coronary heart disease in NIDDM:An incidence study 显示文摘	Mattock M B Barnes D J Viberti G	1998	Diabetes1998，47，：	1
12	Pathogenesis of diabetic nephropathy显示文摘	Viberti G	2001	Exp clin Endocrinol Diabetes2001，109，：	1
13	Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease 显示文摘	Earle K Viberti GC	1994	Kidney Int1994，45，2：	1
14	Glomerular epithelial foot processes and filtration slits in IDDM patients显示文摘	S. F. Bj?rn H. -J. Bangstad K. F. Hanssen G. Nyberg J. D. Walker G. C. Viberti R. ?sterby	1995	Diabetologia1995，，10：	1
15	Microalbum in uria and cardiovascular risk显示文摘	Kralliedde J Viberti G	2004	Am Hypertens2004，17，10：	1
16	Determinants ofurinary albumin excretion within the normal range in patients withtype 2 diabetes : the Randomised Olmesartan and Diabetes Mi-croalbuminuria Prevention ( ROADMAP) study 显示文摘	RITZ E VIBERTI G C RUILOPE L M	2010	Diabetologia2010，53，1：	1
17	Pathogenesis of diabetic nephropathy显示文摘	Raptis A E Viberti G	2001	Exp Clin Endocrinol Diabetes2001，109，2：	1
18	Microalbuminuria as a predictor of clinical nephropathy in insulin - dependent diabetes mellitus 显示文摘	Viberti GC Hill RD Jarret RD	1998	Lancet1998，1，：	1
19	Mechanical forces in diabetic kidney disease:a trigger for impaired glucose metabolism显示文摘	Gnudi L Thomas SM Viberti G		0，，08：	1
20	Microalbuminuria and coronary heart disease in NIDDM显示文摘	Mattock MB Barnes DJ Viberti GC	1998	Diabetes1998，47，11：	1

返回顶部每页显示：

共17页首页上一页第1页下一页末页 /17 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示